Catapult Capital Management’s Edwards Lifesciences EW Stock Holding History

Catapult Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$9.03M	Sell	381,258 -344,460	-47%	-$8.31M	3.42%	2
2015 Q2	$17.2M	Buy	725,718 +125,718	+21%	+$2.84M	2.48%	5
2015 Q1	$14.2M	Buy	600,000 +330,000	+122%	+$7.4M	1.74%	6
2014 Q4	$5.73M	Buy	270,000 +120,000	+80%	+$2.41M	1.46%	19
2014 Q3	$2.55M	Buy	+150,000	New	+$2.37M	0.27%	111
2013 Q4	–	Sell	-120,954	Closed	-$1.4M	–	203
2013 Q3	$1.4M	Buy	+120,954	New	+$1.42M	0.17%	155

Other funds holding EW

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Catapult Capital Management's EW Position: Q3 2015 in Review

Catapult Capital Management reduced its Edwards Lifesciences (EW) stake by 47% in Q3 2015, selling an estimated $8.31M and leaving 381,258 shares worth $9.03M. The position accounts for 3.42% of the portfolio, ranked #2.

Catapult Capital Management first reported a position in EW in Q3 2013 and has held it in 6 quarters since. The position peaked at $17.2M in Q2 2015. 569 funds tracked by Wall St. Rank hold EW as of Q3 2015.

Catapult Capital Management held 381,258 shares of Edwards Lifesciences worth $9.03M as of Q3 2015.
Catapult Capital Management sold 344,460 Edwards Lifesciences shares in Q3 2015, an estimated $8.31M.
Edwards Lifesciences made up 3.42% of Catapult Capital Management's portfolio in Q3 2015, its #2 holding.
Catapult Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 6 quarters since.
Catapult Capital Management's Edwards Lifesciences position peaked at $17.2M in Q2 2015.
569 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.